DSM — Koninklijke DSM NV Share Price
Last trade - 00:00- €19.74bn
- €20.03bn
- €8.39bn
- 86
- 21
- 20
- 35
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 32.79 | ||
| PEG Ratio (f) | 2.72 | ||
| EPS Growth (f) | 13.72% | ||
| Dividend Yield (f) | 2.39% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.84 | ||
| Price to Tang. Book | 3.53 | ||
| Price to Free Cashflow | 62.86 | ||
| Price to Sales | 2.35 | ||
| EV to EBITDA | 15.31 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.6% | ||
| Return on Equity | 4.53% | ||
| Operating Margin | 8.13% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 9,267 | 7,998 | 8,106 | 7,269 | 8,390 | 9,740.56 | 10,475.11 | -0.57% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -36.73 | -31.04 | +5.81 | +9.68 | -44.62 | +7.53 | +21.79 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Its Innovation Center segment focuses on innovation and the growth of DSM’s existing core business through adjacent technologies via its Corporate Research Program, as well as through the Company’s venturing and licensing activities. Its Corporate Activities segment comprises operating and service activities.
Directors
- Robert Routs CSU (75)
- Geraldine Matchett CCE (49)
- Dimitri de Vreeze CCE (54)
- Pauline van der Meer Mohr VSU (61)
- Eileen Kennedy IND
- Thomas Leysen IND (61)
- Erica Mann IND (62)
- Pradeep Pant IND (68)
- John Ramsay IND (63)
- Frits van Paasschen IND (60)
- Last Annual
- December 31st, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- December 28th, 1966
- Public Since
- January 1st, 1989
- No. of Employees
- 20,682
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Euronext - Amsterdam
- Shares in Issue
- 173,075,397
- Address
- Het Overloon 1, HEERLEN, 6411 TE
- Web
- https://www.dsm.com/
- Phone
- +31 455788111
- Contact
- Dave Huizing
- Auditors
- KPMG Accountants NV
Latest News for DSM
Upcoming Events for DSM
Half Year 2023 Koninklijke DSM NV Earnings Release
Q3 2023 Koninklijke DSM NV Trading Statement Release
Similar to DSM
Acomo NV
Euronext - Amsterdam
DSM-Firmenich AG
Euronext - Amsterdam
ForFarmers NV
Euronext - Amsterdam
JDE Peets NV
Euronext - Amsterdam
FAQ
As of Today at 01:06 UTC, shares in Koninklijke DSM NV are trading at €114.05. This share price information is delayed by 15 minutes.
Shares in Koninklijke DSM NV last closed at €114.05 and the price had moved by -21.7% over the past 365 days. In terms of relative price strength the Koninklijke DSM NV share price has underperformed the FTSE Global All Cap Index by -24.73% over the past year.
The overall consensus recommendation for Koninklijke DSM NV is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Koninklijke DSM NV dividend yield is 1.89% based on the trailing twelve month period.
Last year, Koninklijke DSM NV paid a total dividend of €2.15, and it currently has a trailing dividend yield of 1.89%. We do not have any data on when Koninklijke DSM NV is to next pay dividends.
We do not have data on when Koninklijke DSM NV is to next pay dividends. The historic dividend yield on Koninklijke DSM NV shares is currently 1.89%.
To buy shares in Koninklijke DSM NV you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €114.05, shares in Koninklijke DSM NV had a market capitalisation of €19.74bn.
Here are the trading details for Koninklijke DSM NV:
- Country of listing: Netherlands
- Exchange: AEX
- Ticker Symbol: DSM
Based on an overall assessment of its quality, value and momentum Koninklijke DSM NV is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Koninklijke DSM NV is €147.90. That is 29.68% above the last closing price of €114.05.
Analysts covering Koninklijke DSM NV currently have a consensus Earnings Per Share (EPS) forecast of €3.19 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Koninklijke DSM NV. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -10.56%.
As of the last closing price of €114.05, shares in Koninklijke DSM NV were trading -4.6% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Koninklijke DSM NV PE ratio based on its reported earnings over the past 12 months is 32.79. The shares last closed at €114.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Koninklijke DSM NV's management team is headed by:
- Robert Routs - CSU
- Geraldine Matchett - CCE
- Dimitri de Vreeze - CCE
- Pauline van der Meer Mohr - VSU
- Eileen Kennedy - IND
- Thomas Leysen - IND
- Erica Mann - IND
- Pradeep Pant - IND
- John Ramsay - IND
- Frits van Paasschen - IND